Literature DB >> 3081177

Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.

S R Heller, D J Hosking.   

Abstract

Investigation of the renal handling of calcium and sodium in rehydrated patients with hypercalcaemia associated with malignancy showed enhanced reabsorption of calcium in most cases. This was a feature of both metastatic and non-metastatic malignancy, and in this respect the patients were indistinguishable from patients with primary hyperparathyroidism. As the increased calcium reabsorption was inversely correlated with the rate of excretion of sodium modest salt loading can be used to inhibit this process. This is an important practical aspect of the treatment of patients with this type of hypercalcaemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081177      PMCID: PMC1339563          DOI: 10.1136/bmj.292.6520.583

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  20 in total

1.  Relation between serum and urinary calcium with particular reference to parathyroid activity.

Authors:  M Peacock; W G Robertson; B E Nordin
Journal:  Lancet       Date:  1969-02-22       Impact factor: 79.321

2.  New approach to the treatment of hypercalcemia. The effect of short-term treatment with mithramycin.

Authors:  R E Slayton; B I Shnider; E Elias; J Horton; C P Perlia
Journal:  Clin Pharmacol Ther       Date:  1971 Sep-Oct       Impact factor: 6.875

3.  Salmon calcitonin in hypercalcemia.

Authors:  L A Wisneski; W P Croom; O L Silva; K L Becker
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

4.  Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

Authors:  A F Stewart; R Horst; L J Deftos; E C Cadman; R Lang; A E Broadus
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

5.  Hypercalcemic nephropathy.

Authors:  J E Benabe; M Martinez-Maldonado
Journal:  Arch Intern Med       Date:  1978-05

6.  Treatment of acute hypercalcemia with furosemide.

Authors:  J P Fillastre; G Humbert; J Leroy
Journal:  Curr Ther Res Clin Exp       Date:  1973-09

7.  Comparison of the renal and skeletal actions of calcitonin in the treatment of severe hypercalcaemia of malignancy.

Authors:  D J Hosking; D Gilson
Journal:  Q J Med       Date:  1984

8.  Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.

Authors:  M C Chapuy; P J Meunier; C M Alexandre; E P Vignon
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

Review 9.  Calcium transport in the nephron.

Authors:  W N Suki
Journal:  Am J Physiol       Date:  1979-07

10.  Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).

Authors:  F J van Breukelen; O L Bijvoet; A T van Oosterom
Journal:  Lancet       Date:  1979-04-14       Impact factor: 79.321

View more
  8 in total

Review 1.  Assessment of renal and skeletal components of hypercalcemia.

Authors:  D J Hosking
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

2.  Potentiation of calcitonin by corticosteroids during the treatment of the hypercalcaemia of malignancy.

Authors:  D J Hosking; M D Stone; J W Foote
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Hypercalcaemia in malignancy.

Authors:  S H Ralston; S J Gallacher; U Parel; I T Boyle
Journal:  BMJ       Date:  1989-07-15

Review 4.  Medical management of hypercalcaemia.

Authors:  S H Ralston
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

5.  Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer.

Authors:  B M Cantwell; A L Harris
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

6.  Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Authors:  D J Hosking; S R Heller
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 7.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 8.  A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia.

Authors:  Carolina Rodrigues Tonon; Taline Alisson Artemis Lazzarin Silva; Filipe Welson Leal Pereira; Diego Aparecido Rios Queiroz; Edson Luiz Favero Junior; Danilo Martins; Paula Schimdt Azevedo; Marina Politi Okoshi; Leonardo Antonio Mamede Zornoff; Sergio Alberto Rupp de Paiva; Marcos Ferreira Minicucci; Bertha Furlan Polegato
Journal:  Med Sci Monit       Date:  2022-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.